iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Gland Pharma consolidated net profit declines 20.14% in the September 2022 quarter

27 Oct 2022 , 08:12 AM

Net profit of Gland Pharma declined 20.14% to Rs 241.24 crore in the quarter ended September 2022 as against Rs 302.08 crore during the previous quarter ended September 2021. Sales declined 3.34% to Rs 1044.40 crore in the quarter ended September 2022 as against Rs 1080.47 crore during the previous quarter ended September 2021.

Particulars Quarter Ended
? Sep. 2022 Sep. 2021 % Var.
Sales 1044.40 1080.47 -3
OPM % 28.42 34.86
PBDT 360.75 426.78 -15
PBT 324.08 400.67 -19
NP 241.24 302.08 -20

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.